Group 1: Financial Performance - The company achieved a revenue of 1.716 billion CNY in Q1 2025, a decrease of 0.92% year-on-year [2] - Net profit attributable to shareholders was 109 million CNY, an increase of 183.69% year-on-year [2] - The gross profit margin improved to 14.16%, up by 5.95% compared to the same period last year [2] Group 2: Business Segment Performance - Plant extraction business generated 867 million CNY in revenue, a year-on-year increase of 13.78%, with a gross profit of approximately 175 million CNY, up by 27.31% [3] - Cottonseed business revenue was 760 million CNY, a decrease of 9.49%, but gross profit showed significant improvement [3] - Sales of chili red pigment increased by approximately 7% due to a rise in volume [3] Group 3: Product-Specific Insights - Sales of chili extract doubled year-on-year, contributing to a revenue increase of about 24% [3] - Lutein sales volume grew by 50% year-on-year, despite a low price environment due to oversupply [3] - Stevia glycoside sales increased by approximately 55%, with revenue surpassing 8 million CNY [3] Group 4: Market Strategy and Future Outlook - The company plans to enhance its market share in stevia glycosides by expanding its customer base and improving service quality [4] - The cottonseed processing industry is expected to recover in 2025, with improved operational performance compared to the previous year [4] - The company aims to leverage its cost advantages in chili extract to increase its market share both domestically and internationally [4]
晨光生物(300138) - 2025年4月27日投资者关系活动记录表